MARKET

MTP

MTP

Midatech Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.070
0.000
0.00%
After Hours: 2.170 +0.1 +4.83% 16:50 05/18 EDT
OPEN
2.070
PREV CLOSE
2.070
HIGH
2.190
LOW
2.050
VOLUME
183.37K
TURNOVER
--
52 WEEK HIGH
7.07
52 WEEK LOW
1.225
MARKET CAP
26.24M
P/E (TTM)
-0.5846
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Benzinga · 6h ago
Here's Why Midatech Pharma (LON:MTPH) Must Use Its Cash Wisely
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
Simply Wall St. · 1d ago
Pancreatic Cancer Market Size, Share, Trends, Analysis and Forecast 2027
May 12, 2021 (Market Insight Reports) -- The Global Pancreatic Cancer Market is estimated to value over USD 4.7 billion by 2027 end with a CAGR of over 10.2%...
Market Insight Reports · 6d ago
Beyond Meat, Appian among premarket losers' pack
ChemoCentryx (CCXI) -49% after FDA panel split 9-9 on efficacy for Chemocentryx's vasculitis candidate avacopan and reports outcome of FDA’s expert panel meeting on avacopan.Orphazyme  (ORPH) -28% after arimoclomol flunks late-stage amyotrophic lateral scl...
Seekingalpha · 05/07 12:37
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Benzinga · 05/07 12:16
Midatech Shares Spike Higher As Traders Circulate European Patent Office Specification For Co.'s 'NANOPARTICLE-BASED LIVER-TARGETING THERAPY'
https://data.epo.org/publication-server/pdf-document?pn=3576717&ki=B1&cc=EP
Benzinga · 05/05 19:10
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2020
Preliminary Results for the Year Ended 31 December 2020
ACCESSWIRE · 04/30 14:16
Oral Mucositis Drugs Market Size 2021 Research Report by Revenue, Growth Rate, Market Competition, Trends and Forecast to 2024
Apr 23, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Oral mucositis is the most common...
The Express Wire · 04/23 11:45
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of MTP. Analyze the recent business situations of Midatech Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.42%
Pharmaceuticals & Medical Research
+0.07%
Key Executives
Non-Executive Chairman
Rolf Stahel
Chief Executive Officer/Chief Financial Officer/Director
Stephen Stamp
Chief Scientific Officer
Daniel Palmer
Other
Justin Barry
Other
Tim Sparey
Non-Executive Director
Simon De Vries
Non-Executive Independent Director
Simon Turton
No Data
About MTP
Midatech Pharma PLC is a research and development biopharmaceutical company that is focused on commercializing and developing products in oncology and other therapeutic areas. The Company operates through Pipeline Research and Development segment. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Company develops chemo therapeutics or new immune therapeutics, using its drug delivery technologies. Q-Sphera platform is the polymer microsphere technology is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months. Midasolve platform is its nanosaccharide technology is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumours. Midacore platform is the gold nanoparticle technology that is used for targeting sites of disease at the nanoscale.

Webull offers kinds of Midatech Pharma PLC-ADR stock information, including NASDAQ:MTP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTP stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MTP stock methods without spending real money on the virtual paper trading platform.